NICOLE SCHLEGEL: Open Payments
NPI 1609538115 · WEXFORD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,058 in 50 payments from 10 companies in 2025. Trend: 2023 $885 · 2024 $1,700 · 2025 $1,058
Food & beverage: $1,058
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $544 |
| Axsome Therapeutics, Inc. | 4 | $177 |
| Genentech USA, Inc. | 3 | $71 |
| Novartis Pharmaceuticals Corporation | 3 | $68 |
| UCB, Inc. | 3 | $56 |
| Lundbeck LLC | 2 | $36 |
| Biogen, Inc. | 2 | $35 |
| SK Life Science, Inc. | 1 | $32 |
| Medtronic, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $17 |
Products named: QULIPTA, Symbravo, KESIMPTA, Briviact, Ocrevus, UBRELVY, VYEPTI, VUMERITY.
Industry payments across PA — which companies pay providers there.
